HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morris, A. Articles by Mirtallo, J. Search for Related Content PubMed PubMed Citation Articles by Morris, A. Articles by Mirtallo, J.

The compliance of hospitals' quality assurance practices for pharmacy-compounded sterile preparations with the American Society of Health-System Pharmacists (ASHP) Guidelines on Quality Assurance for Pharmacy-Prepared Sterile Products was studied. A survey based on the 2000 ASHP guidelines was developed to determine current practices for compounding sterile preparations in hospital pharmacies. Practices were compared with those identified in a 1995 ASHP survey. The survey was mailed in July 2002 to a stratified random sample of 600 hospital pharmacy directors. There were a total of 182 usable responses, for a net response rate of 30.3%. Quality assurance practices for some quality domains showed low compliance with the 2000 ASHP guidelines. Only 5.2% of pharmacies that compounded risk level 1 preparations were compliant with garb requirements. Only 4.7% of pharmacies compounding risk level 3 preparations were compliant with recommendations for documentation. Compliance with guidelines on the use of resources to determine expiration dates was high (95.5%). Hospitals were moderately compliant with guidelines related to personnel training (62.7%) and labeling (61.1%). Although some improvements were observed, hospital pharmacies in 2002 were still not fully compliant with the ASHP Guidelines on Quality Assurance for Pharmacy-Prepared Sterile Products.

 

This article has been cited by other articles:

				T. T. Horlocker, W. T. Weiss, and C. A. Olson Whodunnit: The Mysterious Case of Mediastinitis After Continuous Interscalene Block Anesth. Analg., October 1, 2008; 107(4): 1095 - 1097. [Full Text] [PDF]

				A. K. Treadway, D. Craddock, and R. Leff Practices of pharmacies that compound extemporaneous formulations Am. J. Health Syst. Pharm., July 1, 2007; 64(13): 1403 - 1409. [Abstract] [Full Text] [PDF]

				P. R. Patel, A. K. Larson, A. D. Castel, L. M. Ganova-Raeva, R. A. Myers, B. J. Roup, K. P. Farrell, L. Edwards, O. Nainan, J. P. Krick, et al. Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies. JAMA, October 25, 2006; 296(16): 2005 - 2011. [Abstract] [Full Text] [PDF]

				T. A. Candy, P. J. Schneider, and C. A. Pedersen Impact of United States Pharmacopeia chapter 797: Results of a national survey. Am. J. Health Syst. Pharm., July 15, 2006; 63(14): 1336 - 1343. [Abstract] [Full Text] [PDF]

				D. Seres, G. S. Sacks, C. A. Pedersen, T. W. Canada, D. Johnson, V. Kumpf, P. Guenter, C. Petersen, and J. Mirtallo Parenteral Nutrition Safe Practices: Results of the 2003 American Society for Parenteral and Enteral Nutrition Survey JPEN J Parenter Enteral Nutr, May 1, 2006; 30(3): 259 - 265. [Abstract] [Full Text] [PDF]

				M. Thomas, M. D. Sanborn, and R. Couldry I.V. admixture contamination rates: Traditional practice site versus a class 1000 cleanroom Am. J. Health Syst. Pharm., November 15, 2005; 62(22): 2386 - 2392. [Abstract] [Full Text] [PDF]

				J. F. Perz, A. S. Craig, C. W. Stratton, S. J. Bodner, W. E. Phillips Jr., and W. Schaffner Pseudomonas putida Septicemia in a Special Care Nursery Due to Contaminated Flush Solutions Prepared in a Hospital Pharmacy J. Clin. Microbiol., October 1, 2005; 43(10): 5316 - 5318. [Abstract] [Full Text] [PDF]